No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms* / drug therapy
-
Breast Neoplasms* / pathology
-
Chemotherapy, Adjuvant
-
Female
-
Humans
-
Neoadjuvant Therapy
-
Receptor, ErbB-2 / metabolism
-
Trastuzumab / therapeutic use
-
Treatment Outcome
Substances
-
Trastuzumab
-
Receptor, ErbB-2